Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Although most patients with type 2 diabetes mellitus can be initially managed with diet and exercise alone, most eventually require at least oral agents if not insulin to maintain glycemic control. Appropriate therapeutic regimens may be difficult to design, given the diversity of drugs available for clinical use. Physicians must consider not only glycemic control, but also patient preference, concomitant medical conditions, and cost when designing therapeutic regimens.


Journal article


Med Clin North Am

Publication Date





757 - 790


Biguanides, Blood Glucose, Chromans, Diabetes Mellitus, Type 2, Diet, Diabetic, Exercise Therapy, Glycoside Hydrolase Inhibitors, Health Care Costs, Humans, Hypoglycemic Agents, Insulin, Patient Compliance, Patient Participation, Sulfonylurea Compounds, Thiazoles, Thiazolidinediones